Quarterly report (Form 10-Q)
Johnson & Johnson 10-Q for Quarter ended Sep 27, 2026
Filing excerpt
Consolidated earnings before provision for taxes on income for the fiscal third quarter of 2026 was $34.0 million representing 0.1% of sales as compared to $7.5 billion in the fiscal third quarter of 2025, representing 31.2% of sales.